相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Systemic toxicity induced by topical application of perfluoroheptanoic acid (PFHpA), perfluorohexanoic acid (PFHxA), and perfluoropentanoic acid (PFPeA) in a murine model
Lisa M. Weatherly et al.
FOOD AND CHEMICAL TOXICOLOGY (2023)
PPARa/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach
Wang Yang et al.
ENVIRONMENT INTERNATIONAL (2023)
Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice
Brecht Attema et al.
MOLECULAR METABOLISM (2022)
Interlaboratory Comparison Investigations (ICIs) and External Quality Assurance Schemes (EQUASs) for human biomonitoring of perfluoroalkyl substances (PFASs) in serum as part of the quality assurance programme under HBM4EU
Stefanie Nuebler et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2022)
Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study
Guoqi Yu et al.
ENVIRONMENT INTERNATIONAL (2021)
Exposure of the French population to bisphenols, phthalates, parabens, glycol ethers, brominated flame retardants, and perfluorinated compounds in 2014-2016: Results from the Esteban study
Clemence Fillol et al.
ENVIRONMENT INTERNATIONAL (2021)
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Chronic exposure to PFO4DA and PFO5DoDA, two perfluoroalkyl ether carboxylic acids (PFECAs), suppresses hepatic stress signals and disturbs glucose and lipid metabolism in male mice
Jiamiao Chen et al.
JOURNAL OF HAZARDOUS MATERIALS (2021)
Serum concentrations of per-/polyfluoroalkyl substances and risk of type 2 diabetes: A case-control study
Yishuang Duan et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2021)
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach
Ran Jin et al.
ENVIRONMENT INTERNATIONAL (2020)
Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children
Nikos Stratakis et al.
HEPATOLOGY (2020)
Association between exposure to per- and polyfluoroalkyl substances and blood glucose in pregnant women
Juxiao Li et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2020)
Persistent organic pollutants and gestational diabetes: A multi-center prospective cohort study of healthy US women
Mohammad L. Rahman et al.
ENVIRONMENT INTERNATIONAL (2019)
Liver function biomarkers disorder is associated with exposure to perfluoroalkyl acids in adults: Isomers of C8 Health Project in China
Min Nian et al.
ENVIRONMENTAL RESEARCH (2019)
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
Jerome Boursier et al.
JOURNAL OF HEPATOLOGY (2019)
Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines
John Bassler et al.
ENVIRONMENTAL POLLUTION (2019)
A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid
Paolo Girardi et al.
ENVIRONMENTAL RESEARCH (2019)
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation
Zobair M. Younossi et al.
TRANSPLANTATION (2019)
Polybrominated diphenyl ethers and perfluorinated alkyl substances in blood serum of New Zealand adults, 2011-2013
J. Coakley et al.
CHEMOSPHERE (2018)
Perfluoroalkyl substances in adolescents in northern Norway: Lifestyle and dietary predictors. The Tromso study, Fit Futures 1
Maria Averina et al.
ENVIRONMENT INTERNATIONAL (2018)
Changes in markers of liver function in relation to changes in perfluoroalkyl substances - A longitudinal study
Samira Salihovic et al.
ENVIRONMENT INTERNATIONAL (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Serum concentrations of perfluorinated compounds among children living in Sicily (Italy)
Caterina Ledda et al.
TOXICOLOGY LETTERS (2018)
ADONA and perfluoroalkylated substances in plasma samples of German blood donors living in South Germany
Hermann Fromme et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2017)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse Revealed by a High-throughput Targeted Metabolomics Approach
Nanyang Yu et al.
SCIENTIFIC REPORTS (2016)
Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study
Panu Rantakokko et al.
ENVIRONMENTAL HEALTH (2015)
Levels of perfluoroalkyl substances and risk of coronary heart disease: Findings from a population-based longitudinal study
Kristina Mattsson et al.
ENVIRONMENTAL RESEARCH (2015)
Perfluorooctanoic acid exposure induces endoplasmic reticulum stress in the liver and its effects are ameliorated by 4-phenylbutyrate
Shengmin Yan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Perinatal Exposure to Perfluorooctane Sulfonate Affects Glucose Metabolism in Adult Offspring
Hin T. Wan et al.
PLOS ONE (2014)
Accumulation of perfluoroalkyl substances in human tissues
Francisca Perez et al.
ENVIRONMENT INTERNATIONAL (2013)
Investigation of the Associations Between Low-Dose Serum Perfluorinated Chemicals and Liver Enzymes in US Adults
Chien-Yu Lin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Altered Fatty Acid Homeostasis and Related Toxicologic Sequelae in Rats Exposed to Dietary Potassium Perfluorooctanesulfonate (PFOS)
Ivan Curran et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2008)
Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice
Hee-Young Son et al.
ARCHIVES OF TOXICOLOGY (2008)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)